The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-up

• NACT use among SGO members for ovarian cancer is explored given recent trials. • Fewer SGO members feel they can't predict optimal cytoreduction pre-operatively. • Laparoscopy use has increased both for diagnosis and treatment of ovarian cancer. • Very high optimal cytoreduction rates are rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Huelsmann, Erica, Zighelboim, Israel, Ahmed, Amina, Dewdney, Summer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Survey Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344220/
https://www.ncbi.nlm.nih.gov/pubmed/28317007
http://dx.doi.org/10.1016/j.gore.2017.02.005
_version_ 1782513493570748416
author Huelsmann, Erica
Zighelboim, Israel
Ahmed, Amina
Dewdney, Summer
author_facet Huelsmann, Erica
Zighelboim, Israel
Ahmed, Amina
Dewdney, Summer
author_sort Huelsmann, Erica
collection PubMed
description • NACT use among SGO members for ovarian cancer is explored given recent trials. • Fewer SGO members feel they can't predict optimal cytoreduction pre-operatively. • Laparoscopy use has increased both for diagnosis and treatment of ovarian cancer. • Very high optimal cytoreduction rates are reported from SGO members. • Despite recent studies, SGO members don't regularly treat patients with NACT/ID.
format Online
Article
Text
id pubmed-5344220
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-53442202017-03-17 The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-up Huelsmann, Erica Zighelboim, Israel Ahmed, Amina Dewdney, Summer Gynecol Oncol Rep Survey Article • NACT use among SGO members for ovarian cancer is explored given recent trials. • Fewer SGO members feel they can't predict optimal cytoreduction pre-operatively. • Laparoscopy use has increased both for diagnosis and treatment of ovarian cancer. • Very high optimal cytoreduction rates are reported from SGO members. • Despite recent studies, SGO members don't regularly treat patients with NACT/ID. Elsevier 2017-02-16 /pmc/articles/PMC5344220/ /pubmed/28317007 http://dx.doi.org/10.1016/j.gore.2017.02.005 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Survey Article
Huelsmann, Erica
Zighelboim, Israel
Ahmed, Amina
Dewdney, Summer
The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-up
title The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-up
title_full The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-up
title_fullStr The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-up
title_full_unstemmed The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-up
title_short The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-up
title_sort role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the society of gynecologic oncologists, a 5-year follow-up
topic Survey Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344220/
https://www.ncbi.nlm.nih.gov/pubmed/28317007
http://dx.doi.org/10.1016/j.gore.2017.02.005
work_keys_str_mv AT huelsmannerica theroleofneoadjuvantchemotherapyinthemanagementofpatientswithadvancedstageovariancancersurveyresultsfrommembersofthesocietyofgynecologiconcologistsa5yearfollowup
AT zighelboimisrael theroleofneoadjuvantchemotherapyinthemanagementofpatientswithadvancedstageovariancancersurveyresultsfrommembersofthesocietyofgynecologiconcologistsa5yearfollowup
AT ahmedamina theroleofneoadjuvantchemotherapyinthemanagementofpatientswithadvancedstageovariancancersurveyresultsfrommembersofthesocietyofgynecologiconcologistsa5yearfollowup
AT dewdneysummer theroleofneoadjuvantchemotherapyinthemanagementofpatientswithadvancedstageovariancancersurveyresultsfrommembersofthesocietyofgynecologiconcologistsa5yearfollowup
AT huelsmannerica roleofneoadjuvantchemotherapyinthemanagementofpatientswithadvancedstageovariancancersurveyresultsfrommembersofthesocietyofgynecologiconcologistsa5yearfollowup
AT zighelboimisrael roleofneoadjuvantchemotherapyinthemanagementofpatientswithadvancedstageovariancancersurveyresultsfrommembersofthesocietyofgynecologiconcologistsa5yearfollowup
AT ahmedamina roleofneoadjuvantchemotherapyinthemanagementofpatientswithadvancedstageovariancancersurveyresultsfrommembersofthesocietyofgynecologiconcologistsa5yearfollowup
AT dewdneysummer roleofneoadjuvantchemotherapyinthemanagementofpatientswithadvancedstageovariancancersurveyresultsfrommembersofthesocietyofgynecologiconcologistsa5yearfollowup

Ejemplares similares